Hello, Friend!
Japan's Takeda Pharmaceutical is in negotiations with Shire after making a third takeover bid worth around US$61 billion that was rejected by the London-listed rare diseases drugmaker.
It’s official: we’re entering conference season. Those lucky enough to be sent by their employers to some exotic clime for a few days of networking know how hard it can be to find somewhere to sta...
A venture capital firm aiming to bring more U.S. startups to Russia has raised a US$200 million fund, hoping to use the fresh pool of money to help Silicon Valley companies deliver their services to R...
China is looking to accelerate plans to develop its domestic semiconductor market amid a fierce trade stand-off with the United States and a U.S. ban on sales to Chinese phone maker ZTE that has under...
PETALING JAYA: Research by a leading international financial newspaper revealed that the Barisan Nasional (BN) is likely to return to power in the 14th General Election (GE).
Hundreds of jobs are reportedly going as New Devices Group shutters and Intel focuses on chips.
